Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients

Clinical trial NCT03150134 · UNKNOWN

Trial details

NCT number: NCT03150134
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Disorder Related to Bone Marrow Transplantation

Start date: 2010-01-01
Primary completion: 2020-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.